Sequoia Financial Advisors LLC Sells 16,546 Shares of Zoetis Inc. $ZTS

Sequoia Financial Advisors LLC reduced its stake in Zoetis Inc. (NYSE:ZTS) by 42.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 22,737 shares of the company’s stock after selling 16,546 shares during the period. Sequoia Financial Advisors LLC’s holdings in Zoetis were worth $3,327,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Baer Investment Advisory LLC grew its position in Zoetis by 13.2% in the third quarter. Baer Investment Advisory LLC now owns 20,391 shares of the company’s stock valued at $2,984,000 after acquiring an additional 2,370 shares during the period. Howland Capital Management LLC increased its holdings in Zoetis by 9.5% during the 3rd quarter. Howland Capital Management LLC now owns 2,341 shares of the company’s stock valued at $343,000 after purchasing an additional 204 shares in the last quarter. Evergreen Capital Management LLC raised its position in Zoetis by 3.3% in the 3rd quarter. Evergreen Capital Management LLC now owns 2,696 shares of the company’s stock valued at $394,000 after purchasing an additional 85 shares during the last quarter. Fulcrum Capital LLC raised its position in Zoetis by 6.1% in the 3rd quarter. Fulcrum Capital LLC now owns 59,847 shares of the company’s stock valued at $8,757,000 after purchasing an additional 3,454 shares during the last quarter. Finally, Arlington Trust Co LLC boosted its stake in Zoetis by 15.2% in the third quarter. Arlington Trust Co LLC now owns 1,106 shares of the company’s stock worth $162,000 after purchasing an additional 146 shares in the last quarter. Institutional investors own 92.80% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently weighed in on the company. KeyCorp assumed coverage on Zoetis in a research note on Thursday, November 20th. They issued a “sector weight” rating for the company. BTIG Research restated a “buy” rating and issued a $160.00 price objective on shares of Zoetis in a research report on Wednesday, December 3rd. UBS Group dropped their price objective on shares of Zoetis from $158.00 to $141.00 and set a “neutral” rating for the company in a research report on Wednesday, November 5th. Morgan Stanley set a $160.00 price target on Zoetis in a research note on Thursday, December 18th. Finally, Weiss Ratings upgraded Zoetis from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Tuesday, January 13th. Six equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $160.18.

Zoetis Stock Performance

ZTS stock opened at $123.24 on Wednesday. Zoetis Inc. has a twelve month low of $115.25 and a twelve month high of $177.40. The company has a quick ratio of 2.28, a current ratio of 3.64 and a debt-to-equity ratio of 1.31. The company has a market cap of $54.31 billion, a P/E ratio of 20.75, a price-to-earnings-growth ratio of 2.53 and a beta of 0.97. The business’s fifty day moving average is $123.37 and its 200-day moving average is $138.85.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.08. Zoetis had a return on equity of 57.19% and a net margin of 28.21%.The business had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.42 billion. During the same quarter in the prior year, the company posted $1.58 earnings per share. The firm’s revenue was up .5% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Equities research analysts forecast that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 3rd. Investors of record on Tuesday, January 20th will be issued a dividend of $0.53 per share. This is an increase from Zoetis’s previous quarterly dividend of $0.50. This represents a $2.12 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date is Tuesday, January 20th. Zoetis’s dividend payout ratio is presently 33.67%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.